Norway · Delayed Price · Currency is NOK BerGenBio ASA Statistics
Total Valuation
BerGenBio ASA has a market cap or net worth of NOK 45.18 million. The enterprise value is -24.33 million.
| Market Cap | 45.18M |
| Enterprise Value | -24.33M |
Important Dates
The next estimated earnings date is Wednesday, November 19, 2025.
| Earnings Date | Nov 19, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
BerGenBio ASA has 39.09 million shares outstanding. The number of shares has increased by 35.14% in one year.
| Current Share Class | 39.09M |
| Shares Outstanding | 39.09M |
| Shares Change (YoY) | +35.14% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 10.58% |
| Owned by Institutions (%) | 6.23% |
| Float | 19.42M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 8.36 |
| PB Ratio | 0.67 |
| P/TBV Ratio | 0.67 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 0.23 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.39
| Current Ratio | 4.39 |
| Quick Ratio | 4.19 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -161.26 |
Financial Efficiency
Return on equity (ROE) is -88.81% and return on invested capital (ROIC) is -59.49%.
| Return on Equity (ROE) | -88.81% |
| Return on Assets (ROA) | -47.22% |
| Return on Invested Capital (ROIC) | -59.49% |
| Return on Capital Employed (ROCE) | -172.08% |
| Revenue Per Employee | 772,143 |
| Profits Per Employee | -15.37M |
| Employee Count | 13 |
| Asset Turnover | 0.04 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -86.71% in the last 52 weeks. The beta is 1.19, so BerGenBio ASA's price volatility has been higher than the market average.
| Beta (5Y) | 1.19 |
| 52-Week Price Change | -86.71% |
| 50-Day Moving Average | 1.18 |
| 200-Day Moving Average | 2.59 |
| Relative Strength Index (RSI) | 48.83 |
| Average Volume (20 Days) | 104,467 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BerGenBio ASA had revenue of NOK 5.41 million and -107.58 million in losses. Loss per share was -2.75.
| Revenue | 5.41M |
| Gross Profit | 5.41M |
| Operating Income | -115.30M |
| Pretax Income | -107.58M |
| Net Income | -107.58M |
| EBITDA | -115.28M |
| EBIT | -115.30M |
| Loss Per Share | -2.75 |
Balance Sheet
The company has 69.51 million in cash and n/a in debt, giving a net cash position of 69.51 million or 1.78 per share.
| Cash & Cash Equivalents | 69.51M |
| Total Debt | n/a |
| Net Cash | 69.51M |
| Net Cash Per Share | 1.78 |
| Equity (Book Value) | 67.00M |
| Book Value Per Share | 1.71 |
| Working Capital | 66.93M |
Cash Flow
| Operating Cash Flow | -137.83M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | 100.00% |
| Operating Margin | -2,133.21% |
| Pretax Margin | -1,990.45% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
BerGenBio ASA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -35.14% |
| Shareholder Yield | -35.14% |
| Earnings Yield | -238.10% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on May 30, 2024. It was a reverse split with a ratio of 0.01.
| Last Split Date | May 30, 2024 |
| Split Type | Reverse |
| Split Ratio | 0.01 |
Scores
BerGenBio ASA has an Altman Z-Score of 4.51 and a Piotroski F-Score of 1.
| Altman Z-Score | 4.51 |
| Piotroski F-Score | 1 |